The dangers of diagnostic monopolies

Nature

Volumn 458, Issue 7237, 2009, Pages 405-406

  Cook Deegan, Robert ^a   Chandrasekharan, Subhashini ^a   Angrist, Misha ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; COLON CANCER; DNA DETERMINATION; GENETIC ANALYSIS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH INSURANCE; HUNTINGTON CHOREA; LICENSING; LONG QT SYNDROME; NOTE; PATENT; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

GENETIC SCREENING; GENOME, HUMAN; GENOMICS; HUMANS; LICENSURE; PATENTS AS TOPIC; PATIENT RIGHTS; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 63649158074     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/458405a     Document Type: Note

References (7)

1. Secretary's Advisory Committee on Genetics, Health, and Society Public Consultation Draft Report on Gene Patents and Licensing Practices and their Impact on Patient Access to Genetic Tests (2009). Available at http://oba.od.nih.gov/SACGHS/sacghs-public-comments.html
2. Walsh, T. et al. J. Am. Med. Assoc. 295, 1379-1388 (2006).
3. Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health (Natl Acad. Press, 2005).
4. Henry, M. R., Cho, M. K., Weaver, M. A. & Merz, J. F. J. Law. Med. Ethics. 31, 442-449 (2003).
5. Cho, M. K. et al. J. Mol. Diagn. 5, 3-8 (2003).
6. In the Public Interest: Nine Points to Consider in Licensing University Technology (Assoc. Univ. Technol. Managers, 2007). Available at www-leland.stanford.edu/group/OTL/industry/resources/whitepaper-10.pdf
7. Jensen K. & Murray F. Science 310, 239-240 (2005).